TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Urologix AB
Closing information (x1000 SEK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
6,956
|
6,952
|
7,621 |
| Financial expenses |
5
|
0
|
0 |
| Earnings before taxes |
2,055
|
1,692
|
2,013 |
| EBITDA |
2,195
|
1,823
|
2,052 |
| Total assets |
2,666
|
2,104
|
2,390 |
| Current assets |
1,047
|
1,227
|
2,171 |
| Current liabilities |
496
|
517
|
575 |
| Equity capital |
2,170
|
1,587
|
1,815 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
81.4%
|
75.4%
|
75.9% |
| Turnover per employee |
1,739
|
1,390
|
1,524 |
| Profit as a percentage of turnover |
29.5%
|
24.3%
|
26.4% |
| Return on assets (ROA) |
77.3%
|
80.4%
|
84.2% |
| Current ratio |
211.1%
|
237.3%
|
377.6% |
| Return on equity (ROE) |
94.7%
|
106.6%
|
110.9% |
| Change turnover |
4
|
-669
|
514 |
| Change turnover % |
0%
|
-9%
|
7% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-20%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.